A clinical-side investment adds multiple physician-directed longevity technologies, pairing with Cellgenic's Cancún lab expansion to establish the city as an integrated RMTG hub.
MIAMI, FL / ACCESS Newswire / November 17, 2026 / Regenerative Medical Technology Group, Inc. (the "Company" or "RMTG") (OTCID:RMTG), a regenerative medicine company operating through its wholly owned subsidiary Global Stem Cells Group, announces an expansion of its Cellular Hope Institute clinical division's facilities in Cancún, Mexico, introducing additional physician-directed longevity, wellness, and complementary technology capabilities.
Copyright 2026 ACCESS Newswire. All Rights Reserved.